Spatial biology has enabled a vast pipeline of discovery and translational biomarker signatures that predict therapeutic response across several clinical indications. In addition, Spatial Biology technology platforms have matured to the point of clinical robustness. This juncture has enabled the first Companion Diagnostic test to be developed in this field that will unfold a new era of precision medicine.